The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
Open accessAbstract
OBJECTIVE: To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents. DESIGN: Meta-analysis of randomised controlled trials. DATA SOURCES: PubMed, Embase, Cumulative Index to Nursing and Allied Health Literature, Scopus, Web of Science, Cochrane Library, and major congress proceedings, searched from 1 January 2002 to 16 February 2015. REVIEW METHODS: Trials comparing short term (<12 months) or extended (>12 months) DAPT regimens with standard 12 month duration of therapy. Primary outcomes were cardiovascular mortality, myocardial infarction, stent thrombosis, major bleeding, and all cause mortality. RESULTS: 10 randomised controlled trials (n=32,287) were included. Compared to 12 month DAPT, a short term course of therapy was associated with a significant reduction in major bleeding (odds ratio 0.58 (95% confidence interval 0.36 to 0.92); P=0.02) with no significant differences in ischaemic or thrombotic outcomes. Extended versus 12 month DAPT yielded a significant reduction in the odds of myocardial infarction (0.53 (0.42 to 0.66); P<0.001) and stent thrombosis (0.33 (0.21 to 0.51); P<0.001), but more major bleeding (1.62 (1.26 to 2.09); P<0.001). All cause but not cardiovascular death was also significantly increased (1.30 (1.02 to 1.66); P=0.03). CONCLUSIONS: Compared with a standard 12 month duration, short term DAPT (<12 months) after drug eluting stent implementation yields reduced bleeding with no apparent increase in ischaemic complications, and could be considered for most patients. In selected patients with low bleeding risk and very high ischaemic risk, extended DAPT (>12 months) could be considered. The increase in all cause but not cardiovascular death with extended DAPT requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Self-citationWriting Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Harbord, R. M., Egger, M., & Sterne, J. A. C. (2006) · Statistics in Medicine · doi:10.1002/sim.2380 · Cited by 2,267
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Mauri, L., Kereiakes, D. J., Yeh, R. W., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Normand, S.-L. T., Braunwald, E., Wiviott, S. D., Cohen, D. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409312 · Cited by 1,928 · cited 2×
“10 Thus, the optimal duration of dual antiplatelet therapy is debated, with short term and extended protocols not yet compared to standard 12 month treatment within the same trial.”
Valgimigli, M., Campo, G., Monti, M., Vranckx, P., Percoco, G., Tumscitz, C., Castriota, F., Colombo, F., Tebaldi, M., Fucà, G., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.071589 · Cited by 672
Self-citationA New Strategy for Discontinuation of Dual Antiplatelet Therapy
Kim, B.-K., Hong, M.-K., Shin, D.-H., Nam, C.-M., Kim, J.-S., Ko, Y.-G., Choi, D., Kang, T.-S., Park, B.-E., Kang, W.-C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.043 · Cited by 646
Gwon, H.-C., Hahn, J.-Y., Park, K. W., Song, Y. B., Chae, I.-H., Lim, D.-S., Han, K.-R., Choi, J.-H., Choi, S.-H., Kang, H.-J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.059022 · Cited by 614
Feres, F. (2013) · JAMA · doi:10.1001/jama.2013.282183 · Cited by 589
Bangalore, S., Kumar, S., Fusaro, M., Amoroso, N., Attubato, M. J., Feit, F., Bhatt, D. L., & Slater, J. (2012) · Circulation · doi:10.1161/circulationaha.112.097014 · Cited by 574
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Park, S.-J., Park, D.-W., Kim, Y.-H., Kang, S.-J., Lee, S.-W., Lee, C. W., Han, K.-H., Park, S.-W., Yun, S.-C., Lee, S.-G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001266 · Cited by 511
Schulz-Schupke, S., Byrne, R. A., ten Berg, J. M., Neumann, F.-J., Han, Y., Adriaenssens, T., Tolg, R., Seyfarth, M., Maeng, M., Zrenner, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu523 · Cited by 431
Colombo, A., Chieffo, A., Frasheri, A., Garbo, R., Masotti-Centol, M., Salvatella, N., Oteo Dominguez, J. F., Steffanon, L., Tarantini, G., Presbitero, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.008 · Cited by 430
Steg, P. G., Huber, K., Andreotti, F., Arnesen, H., Atar, D., Badimon, L., Bassand, J.-P., De Caterina, R., Eikelboom, J. A., Gulba, D., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr204 · Cited by 395
Self-citationGilard, M., Barragan, P., Noryani, A. A. L., Noor, H. A., Majwal, T., Hovasse, T., Castellant, P., Schneeberger, M., Maillard, L., Bressolette, E., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.008 · Cited by 360
Savović, J., Weeks, L., Sterne, J. A., Turner, L., Altman, D. G., Moher, D., & Higgins, J. P. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-37 · Cited by 340
Collet, J.-P., Silvain, J., Barthélémy, O., Rangé, G., Cayla, G., Van Belle, E., Cuisset, T., Elhadad, S., Schiele, F., Lhoest, N., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60612-7 · Cited by 303
Lee, C. W., Ahn, J.-M., Park, D.-W., Kang, S.-J., Lee, S.-W., Kim, Y.-H., Park, S.-W., Han, S., Lee, S.-G., Seong, I.-W., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.003303 · Cited by 284
Navarese, E. P., Tandjung, K., Claessen, B., Andreotti, F., Kowalewski, M., Kandzari, D. E., Kereiakes, D. J., Waksman, R., Mauri, L., Meredith, I. T., et al. (2013) · BMJ · doi:10.1136/bmj.f6530 · Cited by 237
Self-citationClaessen, B. E., Henriques, J. P. S., Jaffer, F. A., Mehran, R., Piek, J. J., & Dangas, G. D. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.05.016 · Cited by 207
Mauri, L., Kereiakes, D. J., Normand, S.-L. T., Wiviott, S. D., Cohen, D. J., Holmes, D. R., Bangalore, S., Cutlip, D. E., Pencina, M., & Massaro, J. M. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.07.038 · Cited by 170
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis
Elmariah, S., Mauri, L., Doros, G., Galper, B. Z., O'Neill, K. E., Steg, P. G., Kereiakes, D. J., & Yeh, R. W. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62052-3 · Cited by 168
Cassese, S., Byrne, R. A., Tada, T., King, L. A., & Kastrati, A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs318 · Cited by 121
Navarese, E. P., Kowalewski, M., Kandzari, D. E., Lansky, A. J., Górny, B., Kołtowski, Ł., Waksman, R., Berti, S. L., Musumeci, G., Limbruno, U., et al. (2014) · Open Heart · doi:10.1136/openhrt-2014-000064 · Cited by 118
Self-citationKikkert, W. J., van Geloven, N., van der Laan, M. H., Vis, M. M., Baan, J., Koch, K. T., Peters, R. J. G., de Winter, R. J., Piek, J. J., Tijssen, J. G. P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.069 · Cited by 111
Collet, J., Cayla, G., Cuisset, T., Elhadad, S., Rangé, G., Vicaut, É., & Montalescot, G. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.09.029 · Cited by 94
Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
Park, S., Park, D., Kim, Y., Kang, S., Lee, S., Lee, C. W., Han, K., Park, S., Yun, S.-C., Lee, S.-G., et al. (2011) · Survey of Anesthesiology · doi:10.1097/01.sa.0000391589.20506.f0 · Cited by 94
Valgimigli, M., Sabaté, M., Kaiser, C., Brugaletta, S., Hernández, J., Galatius, S., Cequier, A. R., Eberli, F. R., de Belder, A., Serruys, P. W. J. C., et al. (2014) · BMJ · doi:10.1136/bmj.g6427 · Cited by 90
Self-citationNavarese, E. P., Schulze, V., Andreotti, F., Kowalewski, M., Kołodziejczak, M. M., Kandzari, D. E., Rassaf, T., Górny, B., Brockmeyer, M., Meyer, C. G., et al. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.10.003 · Cited by 82
Self-citationEl‐Hayek, G. E., Messerli, F. H., Bangalore, S., Hong, M. K., Herzog, E., Benjo, A. M., & Tamis‐Holland, J. E. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.04.035 · Cited by 73
Seeger, P., & Gabrielsson, A. (1968) · Psychological Bulletin · doi:10.1037/h0025667 · Cited by 60
Tarantini, G., Brener, S. J., Barioli, A., Gratta, A., Parodi, G., Rossini, R., Navarese, E. P., Niccoli, G., Frigo, A. C., Musumeci, G., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.11.013 · Cited by 24
Self-citation
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citation2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Self-citationValgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx419 · Cited by 2,987
Self-citationLevine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.513 · Cited by 1,641
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000404 · Cited by 1,355
Metadata
- Authors
- Navarese, E. P., Andreotti, F., Schulze, V., Ko odziejczak, M., Buffon, A., Brouwer, M., Costa, F., Kowalewski, M., Parati, G., Lip, G. Y. H., Kelm, M., & Valgimigli, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2015-04-16
- Volume
- 350
- Issue
- apr16 25
- Pages
- h1618-h1618
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2122594641
- Cited by
- 330
- References
- 37
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.